Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Functional Lung Imaging With DECT and 4DCT
A completed clinical trial evaluated functional lung imaging using dual-energy CT (DECT) and 4DCT in patients with Non-Small Cell Lung Cance…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 [Phase 1]
Phase 1 study of MT-6402 in PD-L1-expressing advanced solid tumors, including non-small cell lung cancer and squamous cell carcinoma of the …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit [NA]
A completed clinical study evaluating DNA extracted from tumor tissue biopsies using the Therascreen KRAS RGQ PCR Kit in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit
Completed clinical trial evaluating the Therascreen KRAS RGQ PCR Kit for analyzing DNA from tumor tissue biopsies in non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients [Phase 3]
Phase 3 trial comparing SAR408701 to docetaxel in CEACAM5-positive metastatic non-squamous non-small cell lung cancer has posted results and…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer [Phase 3]
Phase 3 study comparing Ociperlimab plus Tislelizumab vs Durvalumab after concurrent chemoradiotherapy in stage III unresectable non-small c…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer [NA]
A completed study evaluating a cognitive-behavioral model to reduce dyspnea in patients with lung cancer has been reported.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy [Phase 2]
This Phase 2 clinical trial evaluates the efficacy of low-dose nivolumab added to chemotherapy as neoadjuvant treatment for non-small cell l…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating the combination of vinorelbine and bevacizumab in older adults with stage III or stage IV non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection
A completed clinical trial evaluating a deep learning model to predict recurrence risk after sub-lobar resection in Stage IA invasive lung a…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating surgery and/or radiation therapy or standard therapy or clinical observation in previously treated stage I…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: BT1718 in Patients with Advanced Solid Tumours. [Phase 1, Phase 2]
This clinical trial update reports on BT1718 in patients with advanced solid tumors in Phase 1/2, with the study status completed. Condition…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab with and without radiotherapy in non-small cell lung cancer; results from the completed stud…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer [Phase 2]
Phase 2 results for tislelizumab in combination with chemotherapy as first-line treatment for locally advanced or metastatic non-small cell …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Alvopem® (Pemetrexed) Safety Assessment
Safety data from completed trials of Alvopem (pemetrexed) have been assessed and results are now posted.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy
This clinical trial update reports on FDG PET/CT radiomics analyses in non-small cell lung cancer patients treated with immunotherapy in a c…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib [Phase 1]
Phase 1 trial evaluating pembrolizumab in combination with afatinib for non-small cell lung cancer with resistance to erlotinib; the study i…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib
Post-market surveillance clinical trial evaluating ALK-positive advanced non-small cell lung cancer patients treated with Iruplinalkib; the …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC [Phase 2]
Phase 2 trial evaluating first-line pemetrexed plus cisplatin in patients with advanced non-squamous non-small cell lung cancer; the study w…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study to Evaluate D-1553 in Subjects With Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-1553 in non-small cell lung cancer has completed enrollment and the study status is listed as comple…